Literature DB >> 25680540

Optimising magnetic sentinel lymph node biopsy in an in vivo porcine model.

Muneer Ahmed1, Bauke Anninga1, Joost J Pouw2, Suzan Vreemann2, Mirjam Peek3, Mieke Van Hemelrijck4, Sarah Pinder1, Bennie Ten Haken2, Quentin Pankhurst5, Michael Douek6.   

Abstract

The magnetic technique for sentinel lymph node biopsy (SLNB) has been evaluated in several clinical trials. An in vivo porcine model was developed to optimise the magnetic technique by evaluating the effect of differing volume, concentration and time of injection of magnetic tracer. A total of 60 sentinel node procedures were undertaken. There was a significant correlation between magnetometer counts and iron content of excised sentinel lymph nodes (SLNs) (r=0.82; P<0.001). Total number of SLNs increased with increasing volumes of magnetic tracer (P<0.001). Transcutaneous magnetometer counts increased with increasing time from injection of magnetic tracer (P<0.0001), plateauing within 60min. Increasing concentration resulted in higher iron content of SLNs (P=0.006). Increasing magnetic tracer volume and injecting prior to surgery improve transcutaneous 'hotspot' identification but very high volumes, increase the number of nodes excised. FROM THE CLINICAL EDITOR: Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging of breast cancer patients. Although the current gold standard technique is the combined injection of technetium-labelled nanocolloid and blue dye into the breast, the magnetic technique, using superparamagnetic carboxydextran-coated iron oxide (SPIO), has also been demonstrated as a feasible alternative. In this article, the authors set up to study factors in order to optimize the magnetic tracers.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Magnetic tracer; SLNB: magnetic technique; SPIO; Sentinel lymph node biopsy; Superparamagnetic iron oxide

Mesh:

Substances:

Year:  2015        PMID: 25680540     DOI: 10.1016/j.nano.2015.01.010

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

1.  Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery.

Authors:  Fredrik Wärnberg; Evelina Stigberg; Christine Obondo; Helena Olofsson; Shahin Abdsaleh; Madeleine Wärnberg; Andreas Karakatsanis
Journal:  Ann Surg Oncol       Date:  2019-03-04       Impact factor: 5.344

2.  The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.

Authors:  Andreas Karakatsanis; Peer Michael Christiansen; Lone Fischer; Christina Hedin; Lida Pistioli; Malin Sund; Nils Ryegaard Rasmussen; Hjørdis Jørnsgård; Daniel Tegnelius; Staffan Eriksson; Kosmas Daskalakis; Fredrik Wärnberg; Christos J Markopoulos; Leif Bergkvist
Journal:  Breast Cancer Res Treat       Date:  2016-04-27       Impact factor: 4.872

3.  Combined use of fluorescence with a magnetic tracer and dilution effect upon sentinel node localization in a murine model.

Authors:  Akihiro Kuwahata; Muneer Ahmed; Kohei Saeki; Shinichi Chikaki; Miki Kaneko; Wenqi Qiu; Zonghao Xin; Shinji Yamaguchi; Akiko Kaneko; Michael Douek; Moriaki Kusakabe; Masaki Sekino
Journal:  Int J Nanomedicine       Date:  2018-04-19

4.  Exploratory Study of Superparamagnetic Iron Oxide Dose Optimization in Breast Cancer Sentinel Lymph Node Identification Using a Handheld Magnetic Probe and Iron Quantitation.

Authors:  Kanae Taruno; Akihiko Kuwahata; Masaki Sekino; Takayuki Nakagawa; Tomoko Kurita; Katsutoshi Enokido; Seigo Nakamura; Hiroyuki Takei; Moriaki Kusakabe
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.